GUIDELINE FOR PREPARATION AND PUBLICATION OF PUBLIC ASSESSMENT REPORTS FOR APPROVED MEDICINES Brochure Results on ADR Reports on DTG containing ARV regimens Rosutrox 5 mg, 10 mg, 20 mg and 40 mg film coated tablets_SUMMARY OF PRODUCT CHARACTERISTICS PASURTA (erenumab) 140 mg per mL _ SUMMARY OF PRODUCT CHARACTERISTICS PASURTA (erenumab) 140 mg per mL _ Public assessment summary report_Package label Magnesium sulfate-Kalceks 500 mg per ml solution for injection_SUMMARY OF PRODUCT CHARACTERISTICS OCTANATE 500 and OCTANATE 1000 _SUMMARY OF PRODUCT CHARACTERISTICS OCTANATE 500 and OCTANATE 1000 _ Public assessment summary report Utrogestan Vaginal 100 mg and 200 mg Soft capsules _ Public assessment summary report_Package label Utrogestan Vaginal 100 mg and 200 mg Soft capsules_SUMMARY OF PRODUCT CHARACTERISTICS Minox 5, 50 mg ml, cutaneous solution_SUMMARY OF PRODUCT CHARACTERISTICS Minox 5, 50 mg ml, cutaneous solution_ Public assessment summary report_Package label Delstrigo 100 mg 300 mg 245 mg film-coated tablets_ Public assessment summary report_Package label-1 Delstrigo100 mg 300 mg 245 mg film-coated tablets_SUMMARY OF PRODUCT CHARACTERISTICS CELMANTIN 10 mg and 20 mg film-coated tablets_SUMMARY OF PRODUCT CHARACTERISTICS Verquvo 2.5 mg, 5 mg 10 mg film-coated tablets Summary of product Characteristics Medicine Marketing Authorization Directive No. 963-2023 የመድኃኒት የገበያ ፈቃድ አሰጣጥ መመሪያ ቁጥር 963-2015 CLINICAL TRIAL DIRECTIVE No. 964 2023 የህክምና ሙከራ መመሪያ ቁጥር 964-2015 Brochure-COVID-19 (Covishield-astrazeneca) vaccine active safety monitoring report Guideline for Emergency use Authorization of Medicines for Public Emergency Situations Medicine Donation Control Directive 958-2023 የእርዳታ መድኃኒት ቁጥጥር መመሪያ 958-2015 Summary of product characteristics for Ritonavir Tablets USP 100 mg Summary of product characteristics for Pyrazinamide 150mg Tablets Summary of product characteristics for DOVPRELA (Pretomanid Tablets 200 mg) Public assessment summary report for DOVPRELA (Pretomanid Tablets 200 mg) Summary of product characteristics for Isoniazid 100mg and 300mg tablets Public assessment summary report for Isoniazid 100 and 300 mg tablets Guidelines for Medical devices Clinical Investigation Authorization 803_የኮቪድ_19_ወረርሽኝ_ለመከላከልና_ለመቆጣጣር_ስለሚወሰዱ_ክልከላዎች_እና_ስለሚጣሉ_ግዴታዎች_ለመወሰን የወጣ መመሪያ ቁጥር 803 393_ፕሪከርሰር_ኬሚካሎችን_ለመቆጣጠር_እና_በአግባቡ_ጥቅም_ላይ_ለማዋል_የወጣ_መመሪያ_ቁጥር_393_2012 377 በባለስልጣኑ ስር ለሚገኙ የቴክኒክ ኮሚቴዎች የአበል ክፍያ አፈጻጸም መመሪያ 377_2013 374_የምግብ_መድሀኒትና_የጤና_ክብካቤ_አስተዳደርና_ቁጥጥር_ባለስልጣን_የአንድ_ጊዜ_የመድኃኒት_ግዢ_መመሪያ 369_የናርኮቲክ_መድኃኒቶችንና_የሣይኮትሮፒክ_ንጥረ_ነገር_ማዘዣ_ወረቀት_ለመቆጣጠር_የወጣ_መመሪያ_ቁጥር 369 350 የመድኃኒት፣ የህክምና መገልገያና መሳሪያ አስመጪ፣ ጅምላ አከፋፋይና ላኪ መመሪያ 350 2013 347_ከጨርቅ_የተሰራ_የፊት_መሸፈኛ_ጭንብል_አምራች_የብቃት_ማረጋገጫ_የምስክር_ወረቀት_እና_የገበያ_ፍቃድ 350_የመድኃኒት፣_የህክምና_መገልገያና_መሳሪያ_አስመጪ፣_ጅምላ_አከፋፋይና_ላኪ_መመሪያ_350_2013 338_Pharmaceutical_Manufacturer_GMP_Inspection_Directive_No_338 335_Infant_Formula_and_Follow_up_Formula_Directive_No_335_2020 General Guidelines for Medical devices Marketing Authorization Guideline on requirements of Medical Devices Clearance at ports of entry Regulatory Preparedness and Mitigation Strategy for Emergency Health Threats Medicine Good Manufacturing Practice (GMP) Inspection Procedure Directive 830 2021 Guideline for Classification of In Vitro Diagnostic Medical Devices_EFDA Guideline for Classification of Medical devices other than IVD Medical devices_EFDA Guideline for Application of Accessories and Spare parts_EFDA Guidance on criteria for bundling or grouping of medical devices Guideline for Medical device Post-approval Change Notification_EFDA Guideline for Marketing Authorization of Low risk Medical devices_EFDA Covid-19 vaccine AEFI Reporting Form word document Guidance for Emergency Use Authorization of COVID-19 Vaccine Supplementary guideline for Clinical trial Authorization 2020 Guideline for Registration of oral care skin care products with therapeutic claim Guideline for WHO Pre-qualified Medicines through Collaborative Registration Procedure Good Review Practices (GRevPs) Guideline Guidelines for WHO Pre-qualified Medicines through Collaborative Registration Procedure Guideline for Registration of Low-Risk Medicines Annexes to cosmetic product manufacturing Directive No. 49 2020 Temporary COVID-19 Medical Product Approval and Import Permit Authorization Directive 331_Cosmetics,_Import,_Export_and_Whole_sale_Control_Directive_No 331-2020Title Content Date Document Link doc_category_hfilter Process Flow Diagram of CT Applications Process Flow Diagram of CT Applications May 23, 2023 clinical-trials-amh GUIDELINE FOR PREPARATION AND PUBLICATION OF PUBLIC ASSESSMENT REPORTS FOR APPROVED MEDICINES GUIDELINE FOR PREPARATION AND PUBLICATION OF PUBLIC ASSESSMENT REPORTS FOR APPROVED MEDICINES May 23, 2023 public-assessment-report-for-registered-medicinal-products-amh-2 %e1%8b%a8%e1%88%98%e1%8b%b5%e1%8a%83%e1%8a%92%e1%89%b5-%e1%8c%8b%e1%8b%ad%e1%8b%b5%e1%88%8b%e1%8b%ad%e1%8a%95 Brochure Results on ADR Reports on DTG containing ARV regimens Brochure Results on ADR Reports on DTG containing ARV regimens May 23, 2023 %e1%8b%a8%e1%8d%8b%e1%88%ad%e1%88%9b%e1%8a%ae%e1%89%aa%e1%8c%82%e1%88%8b%e1%8a%95%e1%88%b5-%e1%88%98%e1%8d%85%e1%88%84%e1%89%b5 %e1%88%98%e1%8c%bd%e1%88%94%e1%89%b6%e1%89%bd%e1%8a%93-%e1%8a%a5%e1%8a%93-%e1%89%a0%e1%88%ab%e1%88%a8-%e1%8c%bd%e1%88%91%e1%8d%8e%e1%89%bd Rosutrox 5 mg, 10 mg, 20 mg and 40 mg film coated tablets_SUMMARY OF PRODUCT CHARACTERISTICS Rosutrox 5 mg, 10 mg, 20 mg and 40 mg film coated tablets_SUMMARY OF PRODUCT CHARACTERISTICS May 18, 2023 public-assessment-report-for-registered-medicinal-products-amh-2 Rosutrox 5 mg, 10 mg, 20 mg and 40 mg film coated tablets _ Public assessment summary report_Package label Rosutrox 5 mg, 10 mg, 20 mg and 40 mg film coated tablets _ Public assessment summary report_Package label May 18, 2023 public-assessment-report-for-registered-medicinal-products-amh-2 PASURTA (erenumab) 140 mg per mL _ SUMMARY OF PRODUCT CHARACTERISTICS PASURTA (erenumab) 140 mg per mL _ SUMMARY OF PRODUCT CHARACTERISTICS May 18, 2023 public-assessment-report-for-registered-medicinal-products-amh-2 PASURTA (erenumab) 140 mg per mL _ Public assessment summary report_Package label PASURTA (erenumab) 140 mg per mL _ Public assessment summary report_Package label May 18, 2023 public-assessment-report-for-registered-medicinal-products-amh-2 Magnesium sulfate-Kalceks 500 mg per ml solution for injection_SUMMARY OF PRODUCT CHARACTERISTICS Magnesium sulfate-Kalceks 500 mg per ml solution for injection_SUMMARY OF PRODUCT CHARACTERISTICS May 17, 2023 public-assessment-report-for-registered-medicinal-products-amh-2 OCTANATE 500 and OCTANATE 1000 _SUMMARY OF PRODUCT CHARACTERISTICS OCTANATE 500 and OCTANATE 1000 _SUMMARY OF PRODUCT CHARACTERISTICS May 17, 2023 public-assessment-report-for-registered-medicinal-products-amh-2 OCTANATE 500 and OCTANATE 1000 _ Public assessment summary report OCTANATE 500 and OCTANATE 1000 _ Public assessment summary report May 17, 2023 public-assessment-report-for-registered-medicinal-products-amh-2 Utrogestan Vaginal 100 mg and 200 mg Soft capsules _ Public assessment summary report_Package label Utrogestan Vaginal 100 mg and 200 mg Soft capsules _ Public assessment summary report_Package label May 17, 2023 public-assessment-report-for-registered-medicinal-products-amh-2 Utrogestan Vaginal 100 mg and 200 mg Soft capsules_SUMMARY OF PRODUCT CHARACTERISTICS Utrogestan Vaginal 100 mg and 200 mg Soft capsules_SUMMARY OF PRODUCT CHARACTERISTICS May 17, 2023 public-assessment-report-for-registered-medicinal-products-amh-2 Minox 5, 50 mg ml, cutaneous solution_SUMMARY OF PRODUCT CHARACTERISTICS Minox 5, 50 mg ml, cutaneous solution_SUMMARY OF PRODUCT CHARACTERISTICS May 16, 2023 public-assessment-report-for-registered-medicinal-products-amh-2 Minox 5, 50 mg ml, cutaneous solution_ Public assessment summary report_Package label Minox 5, 50 mg ml, cutaneous solution_ Public assessment summary report_Package label May 16, 2023 public-assessment-report-for-registered-medicinal-products-amh-2 May 16, 2023 public-assessment-report-for-registered-medicinal-products-amh-2 Delstrigo 100 mg 300 mg 245 mg film-coated tablets_ Public assessment summary report_Package label-1 Delstrigo 100 mg 300 mg 245 mg film-coated tablets_ Public assessment summary report_Package label-1 May 16, 2023 public-assessment-report-for-registered-medicinal-products-amh-2 Delstrigo100 mg 300 mg 245 mg film-coated tablets_SUMMARY OF PRODUCT CHARACTERISTICS Delstrigo100 mg 300 mg 245 mg film-coated tablets_SUMMARY OF PRODUCT CHARACTERISTICS May 16, 2023 public-assessment-report-for-registered-medicinal-products-amh-2 CELMANTIN 10 mg and 20 mg film-coated tablets_SUMMARY OF PRODUCT CHARACTERISTICS CELMANTIN 10 mg and 20 mg film-coated tablets_SUMMARY OF PRODUCT CHARACTERISTICS May 16, 2023 public-assessment-report-for-registered-medicinal-products-amh-2 Verquvo 2.5 mg, 5 mg 10 mg film-coated tablets Summary of product Characteristics Verquvo 2.5 mg, 5 mg 10 mg film-coated tablets Summary of product Characteristics May 15, 2023 public-assessment-report-for-registered-medicinal-products-amh-2 Verquvo 2.5 mg, 5 mg 10 mg film-coated tablets_Public assessment summary report and packaging material Verquvo 2.5 mg, 5 mg 10 mg film-coated tablets_Public assessment summary report and packaging material May 15, 2023 public-assessment-report-for-registered-medicinal-products-amh-2 Guideline for Renewal of Medicines Marketing Authorization Guideline for Renewal of Medicines Marketing Authorization May 15, 2023 %e1%8b%a8%e1%88%98%e1%8b%b5%e1%8a%83%e1%8a%92%e1%89%b5-%e1%8c%8b%e1%8b%ad%e1%8b%b5%e1%88%8b%e1%8b%ad%e1%8a%95 National Pharmacovigilance Guideline National Pharmacovigilance Guideline May 12, 2023 pharmacovigilance-amh %e1%8b%a8%e1%88%98%e1%8b%b5%e1%8a%83%e1%8a%92%e1%89%b5-%e1%8c%8b%e1%8b%ad%e1%8b%b5%e1%88%8b%e1%8b%ad%e1%8a%95 J&J Vaccine Brochure J&J Vaccine Brochure May 9, 2023 %e1%8b%a8%e1%8d%8b%e1%88%ad%e1%88%9b%e1%8a%ae%e1%89%aa%e1%8c%82%e1%88%8b%e1%8a%95%e1%88%b5-%e1%88%98%e1%8d%85%e1%88%84%e1%89%b5 %e1%88%98%e1%8c%bd%e1%88%94%e1%89%b6%e1%89%bd%e1%8a%93-%e1%8a%a5%e1%8a%93-%e1%89%a0%e1%88%ab%e1%88%a8-%e1%8c%bd%e1%88%91%e1%8d%8e%e1%89%bd Medicine Marketing Authorization Directive No. 963-2023 የመድኃኒት የገበያ ፈቃድ አሰጣጥ መመሪያ ቁጥር 963-2015 Medicine Marketing Authorization Directive No. 963-2023 የመድኃኒት የገበያ ፈቃድ አሰጣጥ መመሪያ ቁጥር 963-2015 May 4, 2023 %e1%8b%a8%e1%88%98%e1%8b%b5%e1%8a%83%e1%8a%92%e1%89%b5-%e1%88%98%e1%88%98%e1%88%aa%e1%8b%ab%e1%8b%8e%e1%89%bd CLINICAL TRIAL DIRECTIVE No. 964 2023 የህክምና ሙከራ መመሪያ ቁጥር 964-2015 CLINICAL TRIAL DIRECTIVE No. 964 2023 የህክምና ሙከራ መመሪያ ቁጥር 964-2015 May 4, 2023 clinical-trials-amh Brochure-MDR medicines aDSM-TICs analysis report Brochure-MDR medicines aDSM-TICs analysis report April 27, 2023 %e1%8b%a8%e1%8d%8b%e1%88%ad%e1%88%9b%e1%8a%ae%e1%89%aa%e1%8c%82%e1%88%8b%e1%8a%95%e1%88%b5-%e1%88%98%e1%8d%85%e1%88%84%e1%89%b5 %e1%88%98%e1%8c%bd%e1%88%94%e1%89%b6%e1%89%bd%e1%8a%93-%e1%8a%a5%e1%8a%93-%e1%89%a0%e1%88%ab%e1%88%a8-%e1%8c%bd%e1%88%91%e1%8d%8e%e1%89%bd Brochure-COVID-19 (Covishield-astrazeneca) vaccine active safety monitoring report Brochure-COVID-19 (Covishield-astrazeneca) vaccine active safety monitoring report April 27, 2023 %e1%8b%a8%e1%8d%8b%e1%88%ad%e1%88%9b%e1%8a%ae%e1%89%aa%e1%8c%82%e1%88%8b%e1%8a%95%e1%88%b5-%e1%88%98%e1%8d%85%e1%88%84%e1%89%b5 %e1%88%98%e1%8c%bd%e1%88%94%e1%89%b6%e1%89%bd%e1%8a%93-%e1%8a%a5%e1%8a%93-%e1%89%a0%e1%88%ab%e1%88%a8-%e1%8c%bd%e1%88%91%e1%8d%8e%e1%89%bd Brochure-Medsafety mobile app for ADR reporting user guide Brochure-Medsafety mobile app for ADR reporting user guide April 27, 2023 %e1%8b%a8%e1%8d%8b%e1%88%ad%e1%88%9b%e1%8a%ae%e1%89%aa%e1%8c%82%e1%88%8b%e1%8a%95%e1%88%b5-%e1%88%98%e1%8d%85%e1%88%84%e1%89%b5 %e1%88%98%e1%8c%bd%e1%88%94%e1%89%b6%e1%89%bd%e1%8a%93-%e1%8a%a5%e1%8a%93-%e1%89%a0%e1%88%ab%e1%88%a8-%e1%8c%bd%e1%88%91%e1%8d%8e%e1%89%bd Pfizer Vaccine Brochure Pfizer Vaccine Brochure April 27, 2023 %e1%8b%a8%e1%8d%8b%e1%88%ad%e1%88%9b%e1%8a%ae%e1%89%aa%e1%8c%82%e1%88%8b%e1%8a%95%e1%88%b5-%e1%88%98%e1%8d%85%e1%88%84%e1%89%b5 %e1%88%98%e1%8c%bd%e1%88%94%e1%89%b6%e1%89%bd%e1%8a%93-%e1%8a%a5%e1%8a%93-%e1%89%a0%e1%88%ab%e1%88%a8-%e1%8c%bd%e1%88%91%e1%8d%8e%e1%89%bd Guidelines on Reliance for Regulatory Decision Making Guidelines on Reliance for Regulatory Decision Making April 25, 2023 %e1%8b%a8%e1%88%98%e1%8b%b5%e1%8a%83%e1%8a%92%e1%89%b5-%e1%8c%8b%e1%8b%ad%e1%8b%b5%e1%88%8b%e1%8b%ad%e1%8a%95 Pharmacovigilance newsletter 2015 Q3 March Pharmacovigilance newsletter 2015 Q3 March April 24, 2023 %e1%8b%a8%e1%8d%8b%e1%88%ad%e1%88%9b%e1%8a%ae%e1%89%aa%e1%8c%82%e1%88%8b%e1%8a%95%e1%88%b5-%e1%88%98%e1%8d%85%e1%88%84%e1%89%b5 %e1%88%98%e1%8c%bd%e1%88%94%e1%89%b6%e1%89%bd%e1%8a%93-%e1%8a%a5%e1%8a%93-%e1%89%a0%e1%88%ab%e1%88%a8-%e1%8c%bd%e1%88%91%e1%8d%8e%e1%89%bd Pharmacovigilance newsletter 2015 1st quarter Pharmacovigilance newsletter 2015 1st quarter April 24, 2023 %e1%8b%a8%e1%8d%8b%e1%88%ad%e1%88%9b%e1%8a%ae%e1%89%aa%e1%8c%82%e1%88%8b%e1%8a%95%e1%88%b5-%e1%88%98%e1%8d%85%e1%88%84%e1%89%b5 %e1%88%98%e1%8c%bd%e1%88%94%e1%89%b6%e1%89%bd%e1%8a%93-%e1%8a%a5%e1%8a%93-%e1%89%a0%e1%88%ab%e1%88%a8-%e1%8c%bd%e1%88%91%e1%8d%8e%e1%89%bd Guideline for Assessing Medicinal product information Guideline for Assessing Medicinal product information April 3, 2023 %e1%8b%a8%e1%88%98%e1%8b%b5%e1%8a%83%e1%8a%92%e1%89%b5-%e1%8c%8b%e1%8b%ad%e1%8b%b5%e1%88%8b%e1%8b%ad%e1%8a%95 Guideline for Emergency use Authorization of Medicines for Public Emergency Situations Guideline for Emergency use Authorization of Medicines for Public Emergency Situations April 3, 2023 %e1%8b%a8%e1%88%98%e1%8b%b5%e1%8a%83%e1%8a%92%e1%89%b5-%e1%8c%8b%e1%8b%ad%e1%8b%b5%e1%88%8b%e1%8b%ad%e1%8a%95 Guideline for control of medicine advertising and promotion Guideline for control of medicine advertising and promotion April 3, 2023 %e1%8b%a8%e1%88%98%e1%8b%b5%e1%8a%83%e1%8a%92%e1%89%b5-%e1%8c%8b%e1%8b%ad%e1%8b%b5%e1%88%8b%e1%8b%ad%e1%8a%95 List of Authorized Clinical Trial Applications V1, 2015 E.C List of Authorized Clinical Trial Applications V1, 2015 E.C March 10, 2023 clinical-trials-amh የኢትዮጵያ የምግብ እና የመድሐኒት ባለስልጣን አደረጃጀት ሥልጣንና ተግባር መወሰኛ የሚኒስትሮች ምክር ቤት ደንብ ቁጥር 531 2015 የኢትዮጵያ የምግብ እና የመድሐኒት ባለስልጣን አደረጃጀት ሥልጣንና ተግባር መወሰኛ የሚኒስትሮች ምክር ቤት ደንብ ቁጥር 531 2015 March 8, 2023 %e1%8b%b0%e1%8a%95%e1%89%a5 %e1%8d%96%e1%88%8a%e1%88%b2%e1%8b%8e%e1%89%bd%e1%8d%a3-%e1%88%95%e1%8c%8e%e1%89%bd-%e1%8a%a5%e1%8a%93-%e1%8b%b0%e1%8a%95%e1%89%a6%e1%89%bd 957 Traditional medicinal products Manufacturing Certificate of Competence and Market Authorization Directive 957 Traditional medicinal products Manufacturing Certificate of Competence and Market Authorization Directive የባህል መድኃኒት ምርት የብቃት ማረጋገጫ የምስክር ወረቀት እና የገበያ ፈቃድ አሰጣጥ መመሪያ February 1, 2023 %e1%8b%a8%e1%88%98%e1%8b%b5%e1%8a%83%e1%8a%92%e1%89%b5-%e1%8c%8b%e1%8b%ad%e1%8b%b5%e1%88%8b%e1%8b%ad%e1%8a%95 Medicine Donation Control Directive No. 958/2023 Medicine Donation Control Directive 958-2023 የእርዳታ መድኃኒት ቁጥጥር መመሪያ 958-2015 February 1, 2023 %e1%8b%a8%e1%88%98%e1%8b%b5%e1%8a%83%e1%8a%92%e1%89%b5-%e1%88%98%e1%88%98%e1%88%aa%e1%8b%ab%e1%8b%8e%e1%89%bd Summary of product Characteristics of Sildenafil Citrate 50 Summary of product Characteristics of Sildenafil Citrate 50 January 3, 2023 public-assessment-report-for-registered-medicinal-products-amh-2 Public assessment summary report of sildenafil Public assessment summary report of sildenafil January 3, 2023 public-assessment-report-for-registered-medicinal-products-amh-2 Pharmacovigilance newsletter Quarter 1 ,Issue 1 Sep, 2022 Pharmacovigilance newsletter Quarter 1 ,Issue 1 Sep, 2022 December 21, 2022 %e1%8b%a8%e1%8d%8b%e1%88%ad%e1%88%9b%e1%8a%ae%e1%89%aa%e1%8c%82%e1%88%8b%e1%8a%95%e1%88%b5-%e1%88%98%e1%8d%85%e1%88%84%e1%89%b5 %e1%88%98%e1%8c%bd%e1%88%94%e1%89%b6%e1%89%bd%e1%8a%93-%e1%8a%a5%e1%8a%93-%e1%89%a0%e1%88%ab%e1%88%a8-%e1%8c%bd%e1%88%91%e1%8d%8e%e1%89%bd Pharmacovigilance newsletter Volume 1, Issue 1, 2022 Pharmacovigilance newsletter Volume 1, Issue 1, 2022 December 21, 2022 %e1%8b%a8%e1%8d%8b%e1%88%ad%e1%88%9b%e1%8a%ae%e1%89%aa%e1%8c%82%e1%88%8b%e1%8a%95%e1%88%b5-%e1%88%98%e1%8d%85%e1%88%84%e1%89%b5 %e1%88%98%e1%8c%bd%e1%88%94%e1%89%b6%e1%89%bd%e1%8a%93-%e1%8a%a5%e1%8a%93-%e1%89%a0%e1%88%ab%e1%88%a8-%e1%8c%bd%e1%88%91%e1%8d%8e%e1%89%bd Droxiderm SmPC Droxiderm SmPC November 24, 2022 public-assessment-report-for-registered-medicinal-products-amh-2 Droxiderm PAsRv1 Droxiderm PAsRv1 November 24, 2022 public-assessment-report-for-registered-medicinal-products-amh-2 Diclofenac Sodium Injection 75 mg/2 ml Public assessment summary report Diclofenac inj. PAsRv1 November 2, 2022 public-assessment-report-for-registered-medicinal-products-amh-2 SUMMARY OF PRODUCT CHARACTERISTICS DICLOFENAC SODIUM INJECTION 75MG/2ML Diclofenac inj. SmPC V1 November 2, 2022 public-assessment-report-for-registered-medicinal-products-amh-2 AEFI standard reporting form Ethiopia AEFI standard reporting form Ethiopia October 21, 2022 pharmacovigilance-amh Addendum to AEFI Surveillance Guideline 2022 Addendum to AEFI Surveillance Guideline 2022 October 21, 2022 pharmacovigilance-amh ADE-ADR-ME-reporting form-EFDA ADE-ADR-ME-reporting form-EFDA October 21, 2022 pharmacovigilance-amh AEFI-Surviellance & response of AEFI guideline-3rd edition AEFI-Surviellance & response of AEFI guideline-3rd edition October 21, 2022 pharmacovigilance-amh AEFI-Surviellance & response of AEFI guideline-3rd edition AEFI-Surviellance & response of AEFI guideline-3rd edition October 19, 2022 %e1%8b%a8%e1%8d%8b%e1%88%ad%e1%88%9b%e1%8a%ae%e1%89%aa%e1%8c%82%e1%88%8b%e1%8a%95%e1%88%b5-%e1%88%98%e1%8d%85%e1%88%84%e1%89%b5 %e1%88%98%e1%8c%bd%e1%88%94%e1%89%b6%e1%89%bd%e1%8a%93-%e1%8a%a5%e1%8a%93-%e1%89%a0%e1%88%ab%e1%88%a8-%e1%8c%bd%e1%88%91%e1%8d%8e%e1%89%bd ADE-ADR-ME-reporting form-EFDA ADE-ADR-ME-reporting form-EFDA October 19, 2022 %e1%8b%a8%e1%8d%8b%e1%88%ad%e1%88%9b%e1%8a%ae%e1%89%aa%e1%8c%82%e1%88%8b%e1%8a%95%e1%88%b5-%e1%88%98%e1%8d%85%e1%88%84%e1%89%b5 %e1%88%98%e1%8c%bd%e1%88%94%e1%89%b6%e1%89%bd%e1%8a%93-%e1%8a%a5%e1%8a%93-%e1%89%a0%e1%88%ab%e1%88%a8-%e1%8c%bd%e1%88%91%e1%8d%8e%e1%89%bd Addendum to AEFI Surveillance Guideline 2022 Addendum to AEFI Surveillance Guideline 2022 October 19, 2022 %e1%8b%a8%e1%8d%8b%e1%88%ad%e1%88%9b%e1%8a%ae%e1%89%aa%e1%8c%82%e1%88%8b%e1%8a%95%e1%88%b5-%e1%88%98%e1%8d%85%e1%88%84%e1%89%b5 %e1%88%98%e1%8c%bd%e1%88%94%e1%89%b6%e1%89%bd%e1%8a%93-%e1%8a%a5%e1%8a%93-%e1%89%a0%e1%88%ab%e1%88%a8-%e1%8c%bd%e1%88%91%e1%8d%8e%e1%89%bd AEFI standard reporting form Ethiopia AEFI standard reporting form Ethiopia October 19, 2022 %e1%8b%a8%e1%8d%8b%e1%88%ad%e1%88%9b%e1%8a%ae%e1%89%aa%e1%8c%82%e1%88%8b%e1%8a%95%e1%88%b5-%e1%88%98%e1%8d%85%e1%88%84%e1%89%b5 %e1%88%98%e1%8c%bd%e1%88%94%e1%89%b6%e1%89%bd%e1%8a%93-%e1%8a%a5%e1%8a%93-%e1%89%a0%e1%88%ab%e1%88%a8-%e1%8c%bd%e1%88%91%e1%8d%8e%e1%89%bd 932 የመድኃኒት ጎጂ ባህሪያት ክትትል ሥርዓት መመሪያ ቁጥር 932-2015 932 የመድኃኒት ጎጂ ባህሪያት ክትትል ሥርዓት መመሪያ ቁጥር 932-2015 October 17, 2022 %e1%8b%a8%e1%88%98%e1%8b%b5%e1%8a%83%e1%8a%92%e1%89%b5-%e1%88%98%e1%88%98%e1%88%aa%e1%8b%ab%e1%8b%8e%e1%89%bd %e1%8b%a8%e1%8d%8b%e1%88%ad%e1%88%9b%e1%8a%ae%e1%89%aa%e1%8c%82%e1%88%8b%e1%8a%95%e1%88%b5-%e1%88%98%e1%8d%85%e1%88%84%e1%89%b5 %e1%88%98%e1%8c%bd%e1%88%94%e1%89%b6%e1%89%bd%e1%8a%93-%e1%8a%a5%e1%8a%93-%e1%89%a0%e1%88%ab%e1%88%a8-%e1%8c%bd%e1%88%91%e1%8d%8e%e1%89%bd Summary of product characteristics for Ritonavir Tablets USP 100 mg Summary of product characteristics for Ritonavir Tablets USP 100 mg October 17, 2022 public-assessment-report-for-registered-medicinal-products-amh-2 Summary of product characteristics for Pyrazinamide 150mg Tablets Summary of product characteristics for Pyrazinamide 150mg Tablets October 14, 2022 public-assessment-report-for-registered-medicinal-products-amh-2 Summary of product characteristics for DOVPRELA (Pretomanid Tablets 200 mg) Summary of product characteristics for DOVPRELA (Pretomanid Tablets 200 mg) October 14, 2022 public-assessment-report-for-registered-medicinal-products-amh-2 Public assessment summary report for DOVPRELA (Pretomanid Tablets 200 mg) Public assessment summary report for DOVPRELA (Pretomanid Tablets 200 mg) October 14, 2022 public-assessment-report-for-registered-medicinal-products-amh-2 Summary of product characteristics for Isoniazid 100mg and 300mg tablets Summary of product characteristics for Isoniazid 100mg and 300mg tablets October 10, 2022 public-assessment-report-for-registered-medicinal-products-amh-2 Public assessment summary report for Isoniazid 100 and 300 mg tablets Public assessment summary report for Isoniazid 100 and 300 mg tablets October 10, 2022 public-assessment-report-for-registered-medicinal-products-amh-2 PRIVACY POLICY PRIVACY POLICY Last updated March 30, 2022 This privacy notice for Ethiopian Food and Drug Authority (doing business as EFDA) (“EFDA,” “we,” “us,” or “our”), describes how and why we might collect, store, use, and/or … October 8, 2022 %e1%8d%96%e1%88%8a%e1%88%b2%e1%8b%8e%e1%89%bd %e1%8d%96%e1%88%8a%e1%88%b2%e1%8b%8e%e1%89%bd%e1%8d%a3-%e1%88%95%e1%8c%8e%e1%89%bd-%e1%8a%a5%e1%8a%93-%e1%8b%b0%e1%8a%95%e1%89%a6%e1%89%bd Guidelines for Software as Medical Devices Guidelines for Software as Medical Devices September 28, 2022 %e1%8b%a8%e1%88%85%e1%8a%ad%e1%88%9d%e1%8a%93-%e1%88%98%e1%88%a3%e1%88%aa%e1%8b%ab%e1%8b%8e%e1%89%bd-%e1%88%98%e1%88%98%e1%88%aa%e1%8b%ab Guidelines for Medical Device Refurbishment Guidelines for Medical Device Refurbishment September 28, 2022 %e1%8b%a8%e1%88%85%e1%8a%ad%e1%88%9d%e1%8a%93-%e1%88%98%e1%88%a3%e1%88%aa%e1%8b%ab%e1%8b%8e%e1%89%bd-%e1%88%98%e1%88%98%e1%88%aa%e1%8b%ab Guidelines for Medical Device Donations 2022 08 29_Guidelines for Medical Device Donations September 16, 2022 %e1%8b%a8%e1%88%85%e1%8a%ad%e1%88%9d%e1%8a%93-%e1%88%98%e1%88%a3%e1%88%aa%e1%8b%ab%e1%8b%8e%e1%89%bd-%e1%88%98%e1%88%98%e1%88%aa%e1%8b%ab Guideline on variation applications to registered vaccines Guideline on variation applications to registered vaccines September 16, 2022 %e1%8b%a8%e1%88%85%e1%8a%ad%e1%88%9d%e1%8a%93-%e1%88%98%e1%88%a3%e1%88%aa%e1%8b%ab%e1%8b%8e%e1%89%bd-%e1%88%98%e1%88%98%e1%88%aa%e1%8b%ab Guideline on variation applications to registered vaccine GUIDELINE ON VARIATION APPLICATIONS TO REGISTERED VACCINES September 6, 2022 %e1%8b%a8%e1%88%98%e1%8b%b5%e1%8a%83%e1%8a%92%e1%89%b5-%e1%8c%8b%e1%8b%ad%e1%8b%b5%e1%88%8b%e1%8b%ad%e1%8a%95 Emergency medicines list Emergency medicines list September 2, 2022 %e1%8b%a8%e1%88%98%e1%8b%b5%e1%8a%83%e1%8a%92%e1%89%b5-%e1%8b%9d%e1%88%ad%e1%8b%9d%e1%88%ad OTC medicines list OTC medicines list September 2, 2022 %e1%8b%a8%e1%88%98%e1%8b%b5%e1%8a%83%e1%8a%92%e1%89%b5-%e1%8b%9d%e1%88%ad%e1%8b%9d%e1%88%ad Guidelines for Medical devices Clinical Investigation Authorization Guidelines for Medical devices Clinical Investigation Authorization July 26, 2022 %e1%8b%a8%e1%88%85%e1%8a%ad%e1%88%9d%e1%8a%93-%e1%88%98%e1%88%a3%e1%88%aa%e1%8b%ab%e1%8b%8e%e1%89%bd-%e1%88%98%e1%88%98%e1%88%aa%e1%8b%ab Medical devices Decommissioning and Disposal Guideline Medical devices Decommissioning and Disposal Guideline July 18, 2022 %e1%8b%a8%e1%88%85%e1%8a%ad%e1%88%9d%e1%8a%93-%e1%88%98%e1%88%a3%e1%88%aa%e1%8b%ab%e1%8b%8e%e1%89%bd-%e1%88%98%e1%88%98%e1%88%aa%e1%8b%ab Medical Devices Recall Guideline Medical Devices Recall Guideline July 18, 2022 %e1%8b%a8%e1%88%85%e1%8a%ad%e1%88%9d%e1%8a%93-%e1%88%98%e1%88%a3%e1%88%aa%e1%8b%ab%e1%8b%8e%e1%89%bd-%e1%88%98%e1%88%98%e1%88%aa%e1%8b%ab Guidelines for Medical Devices GMP Inspection Guidelines for Medical Devices GMP Inspection May 18, 2022 %e1%8b%a8%e1%88%85%e1%8a%ad%e1%88%9d%e1%8a%93-%e1%88%98%e1%88%a3%e1%88%aa%e1%8b%ab%e1%8b%8e%e1%89%bd-%e1%88%98%e1%88%98%e1%88%aa%e1%8b%ab Ethiopia’s Medicine and Medicine Facility Inspection Process Achieved ISO/IEC 17020:2012 Accreditation Ethiopia’s Medicine and Medicine Facility Inspection Process Achieved ISO/IEC 17020:2012 Accreditation. The Ethiopian Food and Drug Authority is granted accreditation by the Ethiopian National Accreditation Office (ENAO) to perform sampling and inspection in the field … May 10, 2022 accreditations-amh Pharmaceutical Products Barcoding Guideline Pharmaceutical Products Barcoding Guideline May 6, 2022 traceability-amh Guidelines for Medical device Labeling Guidelines for Medical device Labeling April 28, 2022 %e1%8b%a8%e1%88%85%e1%8a%ad%e1%88%9d%e1%8a%93-%e1%88%98%e1%88%a3%e1%88%aa%e1%8b%ab%e1%8b%8e%e1%89%bd-%e1%88%98%e1%88%98%e1%88%aa%e1%8b%ab Hemlibra_Emicizumab_ Summary of product characteristics v1 Hemlibra_Emicizumab_ Summary of product characteristics v1 April 6, 2022 public-assessment-report-for-registered-medicinal-products-amh-2 Hemlibra_Emicizumab_ Public assessment summary reportv1 Hemlibra_Emicizumab_ Public assessment summary reportv1 April 6, 2022 public-assessment-report-for-registered-medicinal-products-amh-2 Lumerax DT 20120_ Artemether 20 mg & Lumefantrine 120 mg Dispersible_public assessment summary report Lumerax DT 20120_ Artemether 20 mg & Lumefantrine 120 mg Dispersible_public assessment summary report March 21, 2022 public-assessment-report-for-registered-medicinal-products-amh-2 Lumerax DT 20120_ Artemether 20 mg & Lumefantrine 120 mg Dispersible_Summary of product characteristics Lumerax DT 20120_ Artemether 20 mg & Lumefantrine 120 mg Dispersible_Summary of product characteristics March 21, 2022 public-assessment-report-for-registered-medicinal-products-amh-2 የኮቪድ 19 ወረርሽኝ ለመከላከልና ለመቆጣጣር ስለሚወሰዱ ክልከላዎች እና ስለሚጣሉ ግዴታዎች ለመወሰን የወጣ መመሪያ ቁጥር 803 803 የኮቪድ19 ወረርሽኝ ለመከላከልና ለመቆጣጣር ስለሚወሰዱ ክልከላዎች እና ስለሚጣሉ ግዴታዎች ለመወሰን የወጣ መመሪያ ቁጥር 803 March 10, 2022 %e1%8b%a8%e1%88%98%e1%8b%b5%e1%8a%83%e1%8a%92%e1%89%b5-%e1%88%98%e1%88%98%e1%88%aa%e1%8b%ab%e1%8b%8e%e1%89%bd ፕሪከርሰር ኬሚካሎችን ለመቆጣጠር እና በአግባቡ ጥቅም ላይ ለማዋል የወጣ መመሪያ ቁጥር 393_2012 393 ፕሪከርሰር ኬሚካሎችን ለመቆጣጠር እና በአግባቡ ጥቅም ላይ ለማዋል የወጣ መመሪያ ቁጥር 393 2012 March 10, 2022 %e1%8b%a8%e1%88%98%e1%8b%b5%e1%8a%83%e1%8a%92%e1%89%b5-%e1%88%98%e1%88%98%e1%88%aa%e1%8b%ab%e1%8b%8e%e1%89%bd ጉድለት የተገኘበት መድኃኒት እና የህክምና መሳሪያ አሰባሰብ መመሪያ ቁጥር_392_2013 392 ጉድለት የተገኘበት መድኃኒት እና የህክምና መሳሪያ አሰባሰብ መመሪያ ቁጥር 392 2013 March 10, 2022 %e1%8b%a8%e1%88%85%e1%8a%ad%e1%88%9d%e1%8a%93-%e1%88%98%e1%88%a3%e1%88%aa%e1%8b%ab%e1%8b%8e%e1%89%bd-%e1%88%98%e1%88%98%e1%88%aa%e1%8b%ab %e1%8b%a8%e1%88%98%e1%8b%b5%e1%8a%83%e1%8a%92%e1%89%b5-%e1%88%98%e1%88%98%e1%88%aa%e1%8b%ab%e1%8b%8e%e1%89%bd በባለስልጣኑ ስር ለሚገኙ የቴክኒክ ኮሚቴዎች የአበል ክፍያ አፈጻጸም መመሪያ 377/2013 377 በባለስልጣኑ ስር ለሚገኙ የቴክኒክ ኮሚቴዎች የአበል ክፍያ አፈጻጸም መመሪያ 377_2013 March 10, 2022 የምግብ መድሀኒትና የጤና ክብካቤ አስተዳደርና ቁጥጥር ባለስልጣን የአንድ ጊዜ የመድኃኒት ግዢ መመሪያ 374 374 የምግብ መድሀኒትና የጤና ክብካቤ አስተዳደርና ቁጥጥር ባለስልጣን የአንድ ጊዜ የመድኃኒት ግዢ መመሪያ March 10, 2022 %e1%8b%a8%e1%88%98%e1%8b%b5%e1%8a%83%e1%8a%92%e1%89%b5-%e1%88%98%e1%88%98%e1%88%aa%e1%8b%ab%e1%8b%8e%e1%89%bd የአልኮል ማስታወቂያና ሽያጭ መመሪያ_372_2013 372_የአልኮል_ማስታወቂያና_ሽያጭ_መመሪያ_372_2013 March 10, 2022 %e1%8b%a8%e1%88%9d%e1%8c%8d%e1%89%a5-%e1%88%98%e1%88%98%e1%88%aa%e1%8b%ab%e1%8b%8e%e1%89%bd የናርኮቲክ መድኃኒቶችንና የሣይኮትሮፒክ ንጥረ ነገር ማዘዣ ወረቀት ለመቆጣጠር የወጣ መመሪያ ቁጥር 369 369 የናርኮቲክ መድኃኒቶችንና የሣይኮትሮፒክ ንጥረ ነገር ማዘዣ ወረቀት ለመቆጣጠር የወጣ መመሪያ ቁጥር 369 March 10, 2022 %e1%8b%a8%e1%88%98%e1%8b%b5%e1%8a%83%e1%8a%92%e1%89%b5-%e1%88%98%e1%88%98%e1%88%aa%e1%8b%ab%e1%8b%8e%e1%89%bd የምግብ ጨው ቁጥጥር መመሪያ 361-2013 361 የምግብ ጨው ቁጥጥር መመሪያ 361-2013 March 10, 2022 %e1%8b%a8%e1%88%9d%e1%8c%8d%e1%89%a5-%e1%88%98%e1%88%98%e1%88%aa%e1%8b%ab%e1%8b%8e%e1%89%bd የምግብ ላኪ፣ አስመጪና አከፋፋይ ቁጥጥር መመሪያ ቁጥር 357_2013 357 የምግብ ላኪ፣ አስመጪና አከፋፋይ ቁጥጥር መመሪያ ቁጥር 357 2013 March 10, 2022 %e1%8b%a8%e1%88%9d%e1%8c%8d%e1%89%a5-%e1%88%98%e1%88%98%e1%88%aa%e1%8b%ab%e1%8b%8e%e1%89%bd የመድኃኒትና የህክምና መሣሪያ ማስተዋወቅ መመሪያ ቁጥር 253_2013 353 የመድኃኒትና የህክምና መሣሪያ ማስተዋወቅ መመሪያ ቁጥር 253 2013 March 10, 2022 %e1%8b%a8%e1%88%85%e1%8a%ad%e1%88%9d%e1%8a%93-%e1%88%98%e1%88%a3%e1%88%aa%e1%8b%ab%e1%8b%8e%e1%89%bd-%e1%88%98%e1%88%98%e1%88%aa%e1%8b%ab %e1%8b%a8%e1%88%98%e1%8b%b5%e1%8a%83%e1%8a%92%e1%89%b5-%e1%88%98%e1%88%98%e1%88%aa%e1%8b%ab%e1%8b%8e%e1%89%bd የመድኃኒት፣ የህክምና መገልገያና መሳሪያ አስመጪ፣ ጅምላ አከፋፋይና ላኪ መመሪያ 350_2013 350 የመድኃኒት፣ የህክምና መገልገያና መሳሪያ አስመጪ፣ ጅምላ አከፋፋይና ላኪ መመሪያ 350 2013 March 10, 2022 %e1%8b%a8%e1%88%85%e1%8a%ad%e1%88%9d%e1%8a%93-%e1%88%98%e1%88%a3%e1%88%aa%e1%8b%ab%e1%8b%8e%e1%89%bd-%e1%88%98%e1%88%98%e1%88%aa%e1%8b%ab %e1%8b%a8%e1%88%98%e1%8b%b5%e1%8a%83%e1%8a%92%e1%89%b5-%e1%88%98%e1%88%98%e1%88%aa%e1%8b%ab%e1%8b%8e%e1%89%bd የመድኃኒት ችርቻሮ ድርጅቶች ቁጥጥር መመሪያ ቁጥር 349_2013 349 የመድኃኒት ችርቻሮ ድርጅቶች ቁጥጥር መመሪያ ቁጥር 349 2013 March 10, 2022 %e1%8b%a8%e1%88%98%e1%8b%b5%e1%8a%83%e1%8a%92%e1%89%b5-%e1%88%98%e1%88%98%e1%88%aa%e1%8b%ab%e1%8b%8e%e1%89%bd ከጨርቅ የተሰራ የፊት መሸፈኛ ጭንብል አምራች የብቃት ማረጋገጫ የምስክር ወረቀት እና የገበያ ፍቃድ 347 347 ከጨርቅ የተሰራ የፊት መሸፈኛ ጭንብል አምራች የብቃት ማረጋገጫ የምስክር ወረቀት እና የገበያ ፍቃድ March 10, 2022 %e1%8b%a8%e1%88%98%e1%8b%b5%e1%8a%83%e1%8a%92%e1%89%b5-%e1%88%98%e1%88%98%e1%88%aa%e1%8b%ab%e1%8b%8e%e1%89%bd አግባባዊ የመድኃኒት አጠቃቀም ቁጥጥር መመሪያ ቁጥር 346 2013 346 አግባባዊ የመድኃኒት አጠቃቀም ቁጥጥር መመሪያ ቁጥ 346 2013 March 10, 2022 %e1%8b%a8%e1%88%98%e1%8b%b5%e1%8a%83%e1%8a%92%e1%89%b5-%e1%88%98%e1%88%98%e1%88%aa%e1%8b%ab%e1%8b%8e%e1%89%bd የመድኃኒት፣_የህክምና_መገልገያና_መሳሪያ_አስመጪ፣_ጅምላ_አከፋፋይና_ላኪ_መመሪያ_350_2013 350_የመድኃኒት፣_የህክምና_መገልገያና_መሳሪያ_አስመጪ፣_ጅምላ_አከፋፋይና_ላኪ_መመሪያ_350_2013 March 10, 2022 %e1%8b%a8%e1%88%98%e1%8b%b5%e1%8a%83%e1%8a%92%e1%89%b5-%e1%88%98%e1%88%98%e1%88%aa%e1%8b%ab%e1%8b%8e%e1%89%bd Administrative Measure Taking and Complaint Handling Directive No_345_2013 345 አስተዳደራዊ እርምጃ አወሳሰድና ቅሬታ አቀራረብ መመሪያ ቁጥር 345 2013 March 10, 2022 Pharmaceutical Manufacturer GMP Inspection Directive No 338 338 Pharmaceutical Manufacturer GMP Inspection Directive No 338 March 10, 2022 %e1%8b%a8%e1%88%98%e1%8b%b5%e1%8a%83%e1%8a%92%e1%89%b5-%e1%88%98%e1%88%98%e1%88%aa%e1%8b%ab%e1%8b%8e%e1%89%bd Medical Equipment Donation Directive No. 336-2020 336 Medical Equipment Donation Directive No. 336-2020 March 10, 2022 %e1%8b%a8%e1%88%9d%e1%8c%8d%e1%89%a5-%e1%88%98%e1%88%98%e1%88%aa%e1%8b%ab%e1%8b%8e%e1%89%bd Infant Formula and Follow up Formula Directive No 335 2020 335 Infant Formula and Follow up Formula Directive No 335 2020 March 10, 2022 %e1%8b%a8%e1%88%9d%e1%8c%8d%e1%89%a5-%e1%88%98%e1%88%98%e1%88%aa%e1%8b%ab%e1%8b%8e%e1%89%bd Graphic_Health_Warning_directive_No 334_2013 March 10, 2022 Food Supplement Directive No. 333-2020 333 Food Supplement Directive No. 333-2020 March 10, 2022 %e1%8b%a8%e1%88%9d%e1%8c%8d%e1%89%a5-%e1%88%98%e1%88%98%e1%88%aa%e1%8b%ab%e1%8b%8e%e1%89%bd Guidelines for Medical Devices Good Clinical Practices Guidelines for Medical Devices Good Clinical Practices March 8, 2022 %e1%8b%a8%e1%88%85%e1%8a%ad%e1%88%9d%e1%8a%93-%e1%88%98%e1%88%a3%e1%88%aa%e1%8b%ab%e1%8b%8e%e1%89%bd-%e1%88%98%e1%88%98%e1%88%aa%e1%8b%ab Medicine and Medical Device Import, Export and Wholesale Control Directive 872/2022 Medicine and Medical Device Import Export and Wholesale Control Directive 8722022 February 22, 2022 %e1%8b%a8%e1%88%85%e1%8a%ad%e1%88%9d%e1%8a%93-%e1%88%98%e1%88%a3%e1%88%aa%e1%8b%ab%e1%8b%8e%e1%89%bd-%e1%88%98%e1%88%98%e1%88%aa%e1%8b%ab %e1%8b%a8%e1%88%98%e1%8b%b5%e1%8a%83%e1%8a%92%e1%89%b5-%e1%88%98%e1%88%98%e1%88%aa%e1%8b%ab%e1%8b%8e%e1%89%bd Master data Guideline _2nd Edition 2022 Master data Guideline _2nd Edition 2022 February 7, 2022 traceability-amh Ethiopian AMR PC_Strategic Plan 2021_2025 Ethiopian AMR PC_Strategic Plan 2021_2025 February 2, 2022 %e1%88%b5%e1%88%8d%e1%89%b6%e1%89%bd Pharmaceutical Products Barcoding Guideline Pharmaceutical Products Barcoding Guideline January 27, 2022 traceability-amh Risk Management Plan Guideline for COVID-19 Vaccines Risk Management Plan Guideline for COVID-19 Vaccines January 27, 2022 %e1%8b%a8%e1%88%98%e1%8b%b5%e1%8a%83%e1%8a%92%e1%89%b5-%e1%8c%8b%e1%8b%ad%e1%8b%b5%e1%88%8b%e1%8b%ad%e1%8a%95 General Guidelines for Medical devices Marketing Authorization General Guidelines for Medical devices Marketing Authorization January 25, 2022 %e1%8b%a8%e1%88%85%e1%8a%ad%e1%88%9d%e1%8a%93-%e1%88%98%e1%88%a3%e1%88%aa%e1%8b%ab%e1%8b%8e%e1%89%bd-%e1%88%98%e1%88%98%e1%88%aa%e1%8b%ab Guideline on requirements of Medical Devices Clearance at ports of entry Guideline on requirements of Medical Devices Clearance at ports of entry January 24, 2022 %e1%8b%a8%e1%88%85%e1%8a%ad%e1%88%9d%e1%8a%93-%e1%88%98%e1%88%a3%e1%88%aa%e1%8b%ab%e1%8b%8e%e1%89%bd-%e1%88%98%e1%88%98%e1%88%aa%e1%8b%ab Guidelines for Medical Device GDP and GSP Guidelines for Medical Device GDP and GSP January 20, 2022 %e1%8b%a8%e1%88%85%e1%8a%ad%e1%88%9d%e1%8a%93-%e1%88%98%e1%88%a3%e1%88%aa%e1%8b%ab%e1%8b%8e%e1%89%bd-%e1%88%98%e1%88%98%e1%88%aa%e1%8b%ab Global Trade Item Number (GTIN) Allocation Guideline Global Trade Item Number (GTIN) Allocation Guideline January 17, 2022 traceability-amh Global Location Number (GLN) Allocation Guideline Global Location Number (GLN) Allocation Guideline January 17, 2022 traceability-amh Emergency Medicine List second edition Emergency Medicine List second edition December 30, 2021 %e1%8b%a8%e1%88%98%e1%8b%b5%e1%8a%83%e1%8a%92%e1%89%b5-%e1%8b%9d%e1%88%ad%e1%8b%9d%e1%88%ad GMP Application form GMP Application form December 30, 2021 %e1%8b%a8%e1%88%98%e1%8b%b5%e1%8a%83%e1%8a%92%e1%89%b5-%e1%8c%8b%e1%8b%ad%e1%8b%b5%e1%88%8b%e1%8b%ad%e1%8a%95 INIGAST 40 Public assessment summary report v1 INIGAST 40 Public assessment summary report v1 December 15, 2021 public-assessment-report-for-registered-medicinal-products-amh-2 INIGAST 40 Summary of product characteristics v1 INIGAST 40 Summary of product characteristics v1 December 15, 2021 public-assessment-report-for-registered-medicinal-products-amh-2 ALLTERA 50 Summary of product characteristics v1 ALLTERA 50 Summary of product characteristics v1 December 15, 2021 public-assessment-report-for-registered-medicinal-products-amh-2 ALLTERA 50 Public assessment summary report v1 ALLTERA 50 Public assessment summary report v1 December 15, 2021 public-assessment-report-for-registered-medicinal-products-amh-2 ALLTERA 50 Public assessment summary report v1 ALLTERA 50 Public assessment summary report v1 December 14, 2021 Baby food control directive 840-2021 Baby food control directive 840-2021 November 25, 2021 %e1%8b%a8%e1%88%9d%e1%8c%8d%e1%89%a5-%e1%88%98%e1%88%98%e1%88%aa%e1%8b%ab%e1%8b%8e%e1%89%bd Guideline for Medical Devices Good Manufacturing Practice Guideline for Medical Devices Good Manufacturing Practice November 1, 2021 %e1%8b%a8%e1%88%85%e1%8a%ad%e1%88%9d%e1%8a%93-%e1%88%98%e1%88%a3%e1%88%aa%e1%8b%ab%e1%8b%8e%e1%89%bd-%e1%88%98%e1%88%98%e1%88%aa%e1%8b%ab Baby Food Control Directive Number 840 2021 Baby Food Control Directive Number 840 2021 November 1, 2021 %e1%8b%a8%e1%88%9d%e1%8c%8d%e1%89%a5-%e1%88%98%e1%88%98%e1%88%aa%e1%8b%ab%e1%8b%8e%e1%89%bd Regulatory Preparedness and Mitigation Strategy for Emergency Health Threats Regulatory Preparedness and Mitigation Strategy for Emergency Health Threats October 11, 2021 %e1%88%b5%e1%88%8d%e1%89%b6%e1%89%bd Guidelines for Borderline Medical devices_EFDA Guidelines for Borderline Medical devices_EFDA October 8, 2021 %e1%8b%a8%e1%88%85%e1%8a%ad%e1%88%9d%e1%8a%93-%e1%88%98%e1%88%a3%e1%88%aa%e1%8b%ab%e1%8b%8e%e1%89%bd-%e1%88%98%e1%88%98%e1%88%aa%e1%8b%ab Guideline for Registration of Medicines 2020 Guideline for Registration of Medicines 2020 September 13, 2021 %e1%8b%a8%e1%88%98%e1%8b%b5%e1%8a%83%e1%8a%92%e1%89%b5-%e1%8c%8b%e1%8b%ad%e1%8b%b5%e1%88%8b%e1%8b%ad%e1%8a%95 የመድኃኒት የመልካም አመራረት ስርዓት ቁጥጥር አሰራር መመሪያ 830 2013 የመድኃኒት የመልካም አመራረት ስርዓት ቁጥጥር አሰራር መመሪያ 830 2013 September 13, 2021 %e1%8b%a8%e1%88%98%e1%8b%b5%e1%8a%83%e1%8a%92%e1%89%b5-%e1%88%98%e1%88%98%e1%88%aa%e1%8b%ab%e1%8b%8e%e1%89%bd Medicine Good Manufacturing Practice (GMP) Inspection Procedure Directive 830 2021 Medicine Good Manufacturing Practice (GMP) Inspection Procedure Directive 830 2021 September 13, 2021 %e1%8b%a8%e1%88%98%e1%8b%b5%e1%8a%83%e1%8a%92%e1%89%b5-%e1%88%98%e1%88%98%e1%88%aa%e1%8b%ab%e1%8b%8e%e1%89%bd Guideline for Registration of Insecticide Treated Net 2021 Guideline for Registration of Insecticide Treated Net 2021 August 4, 2021 %e1%8b%a8%e1%88%98%e1%8b%b5%e1%8a%83%e1%8a%92%e1%89%b5-%e1%8c%8b%e1%8b%ad%e1%8b%b5%e1%88%8b%e1%8b%ad%e1%8a%95 Guideline for Classification of In Vitro Diagnostic Medical Devices_EFDA Guideline for Classification of In Vitro Diagnostic Medical Devices_EFDA July 21, 2021 %e1%8b%a8%e1%88%85%e1%8a%ad%e1%88%9d%e1%8a%93-%e1%88%98%e1%88%a3%e1%88%aa%e1%8b%ab%e1%8b%8e%e1%89%bd-%e1%88%98%e1%88%98%e1%88%aa%e1%8b%ab Guideline for Classification of Medical devices other than IVD Medical devices_EFDA Guideline for Classification of Medical devices other than IVD Medical devices_EFDA July 21, 2021 %e1%8b%a8%e1%88%85%e1%8a%ad%e1%88%9d%e1%8a%93-%e1%88%98%e1%88%a3%e1%88%aa%e1%8b%ab%e1%8b%8e%e1%89%bd-%e1%88%98%e1%88%98%e1%88%aa%e1%8b%ab Guidance on waiver of in vivo bioequivalence requirements Guidance on waiver of in vivo bioequivalence requirements July 14, 2021 %e1%8b%a8%e1%88%98%e1%8b%b5%e1%8a%83%e1%8a%92%e1%89%b5-%e1%8c%8b%e1%8b%ad%e1%8b%b5%e1%88%8b%e1%8b%ad%e1%8a%95 Guideline on variation applications to registered medicines Guideline on variation applications to registered medicines July 14, 2021 %e1%8b%a8%e1%88%98%e1%8b%b5%e1%8a%83%e1%8a%92%e1%89%b5-%e1%8c%8b%e1%8b%ad%e1%8b%b5%e1%88%8b%e1%8b%ad%e1%8a%95 Guideline for Application of Accessories and Spare parts_EFDA Guideline for Application of Accessories and Spare parts_EFDA July 12, 2021 %e1%8b%a8%e1%88%85%e1%8a%ad%e1%88%9d%e1%8a%93-%e1%88%98%e1%88%a3%e1%88%aa%e1%8b%ab%e1%8b%8e%e1%89%bd-%e1%88%98%e1%88%98%e1%88%aa%e1%8b%ab Guideline for Medical Devices Bundling for Marketing authorization application Guidance on criteria for bundling or grouping of medical devices May 6, 2021 %e1%8b%a8%e1%88%85%e1%8a%ad%e1%88%9d%e1%8a%93-%e1%88%98%e1%88%a3%e1%88%aa%e1%8b%ab%e1%8b%8e%e1%89%bd-%e1%88%98%e1%88%98%e1%88%aa%e1%8b%ab የትምባሆ ቁጥጥር መመሪያ 771 2013 771 የትምባሆ ቁጥጥር መመሪያ April 20, 2021 tobacco-amh Master Data Guideline_March 2021 Master Data Guideline_March 2021 April 19, 2021 traceability-amh National-pharmacovigilance-Roadmap-2020 National-pharmacovigilance-Roadmap-2020 April 13, 2021 %e1%8b%a8%e1%8d%8b%e1%88%ad%e1%88%9b%e1%8a%ae%e1%89%aa%e1%8c%82%e1%88%8b%e1%8a%95%e1%88%b5-%e1%88%98%e1%8d%85%e1%88%84%e1%89%b5 %e1%88%98%e1%8c%bd%e1%88%94%e1%89%b6%e1%89%bd%e1%8a%93-%e1%8a%a5%e1%8a%93-%e1%89%a0%e1%88%ab%e1%88%a8-%e1%8c%bd%e1%88%91%e1%8d%8e%e1%89%bd Guideline for Medical device Post-approval Change Notification EFDA Guideline for Medical device Post-approval Change Notification_EFDA April 5, 2021 %e1%8b%a8%e1%88%85%e1%8a%ad%e1%88%9d%e1%8a%93-%e1%88%98%e1%88%a3%e1%88%aa%e1%8b%ab%e1%8b%8e%e1%89%bd-%e1%88%98%e1%88%98%e1%88%aa%e1%8b%ab Guideline for Marketing Authorization of Low risk Medical devices_EFDA Guideline for Marketing Authorization of Low risk Medical devices_EFDA April 5, 2021 %e1%8b%a8%e1%88%85%e1%8a%ad%e1%88%9d%e1%8a%93-%e1%88%98%e1%88%a3%e1%88%aa%e1%8b%ab%e1%8b%8e%e1%89%bd-%e1%88%98%e1%88%98%e1%88%aa%e1%8b%ab Covid-19 vaccine AEFI Reporting Form Covid-19 vaccine AEFI Reporting Form word document March 12, 2021 %e1%8b%a8%e1%8d%8b%e1%88%ad%e1%88%9b%e1%8a%ae%e1%89%aa%e1%8c%82%e1%88%8b%e1%8a%95%e1%88%b5-%e1%88%98%e1%8d%85%e1%88%84%e1%89%b5 %e1%88%98%e1%8c%bd%e1%88%94%e1%89%b6%e1%89%bd%e1%8a%93-%e1%8a%a5%e1%8a%93-%e1%89%a0%e1%88%ab%e1%88%a8-%e1%8c%bd%e1%88%91%e1%8d%8e%e1%89%bd Covid-19 vaccine AEFI Reporting Form Covid-19 vaccine AEFI Reporting Form March 12, 2021 %e1%8b%a8%e1%8d%8b%e1%88%ad%e1%88%9b%e1%8a%ae%e1%89%aa%e1%8c%82%e1%88%8b%e1%8a%95%e1%88%b5-%e1%88%98%e1%8d%85%e1%88%84%e1%89%b5 %e1%88%98%e1%8c%bd%e1%88%94%e1%89%b6%e1%89%bd%e1%8a%93-%e1%8a%a5%e1%8a%93-%e1%89%a0%e1%88%ab%e1%88%a8-%e1%8c%bd%e1%88%91%e1%8d%8e%e1%89%bd Guideline for Registration of Antiseptics and Disinfectants Guideline for Registration of Antiseptics and Disinfectants March 6, 2021 %e1%8b%a8%e1%88%98%e1%8b%b5%e1%8a%83%e1%8a%92%e1%89%b5-%e1%8c%8b%e1%8b%ad%e1%8b%b5%e1%88%8b%e1%8b%ad%e1%8a%95 EFDA_Guidelines for IVD Registration Requirements EFDA_Guidelines for IVD Registration Requirements February 19, 2021 %e1%8b%a8%e1%88%85%e1%8a%ad%e1%88%9d%e1%8a%93-%e1%88%98%e1%88%a3%e1%88%aa%e1%8b%ab%e1%8b%8e%e1%89%bd-%e1%88%98%e1%88%98%e1%88%aa%e1%8b%ab EFDA_Guidelines for Non-IVD Registration Requirements EFDA_Guidelines for Non-IVD Registration Requirements February 19, 2021 %e1%8b%a8%e1%88%85%e1%8a%ad%e1%88%9d%e1%8a%93-%e1%88%98%e1%88%a3%e1%88%aa%e1%8b%ab%e1%8b%8e%e1%89%bd-%e1%88%98%e1%88%98%e1%88%aa%e1%8b%ab Guideline for COVID-19 Vaccine donation Guideline for COVID-19 Vaccine donation This Donation Guideline is intended to provide guidance to applicants wishing to donate or receive Covid-19 vaccines. This will be a “living document” and will be updated on a regular … February 15, 2021 %e1%8b%a8%e1%88%98%e1%8b%b5%e1%8a%83%e1%8a%92%e1%89%b5-%e1%8c%8b%e1%8b%ad%e1%8b%b5%e1%88%8b%e1%8b%ad%e1%8a%95 Guidance for Emergency Use Authorization of COVID-19 Vaccine Guidance for Emergency Use Authorization of COVID-19 Vaccine January 29, 2021 %e1%8b%a8%e1%88%98%e1%8b%b5%e1%8a%83%e1%8a%92%e1%89%b5-%e1%8c%8b%e1%8b%ad%e1%8b%b5%e1%88%8b%e1%8b%ad%e1%8a%95 Guideline for Conditional Approval of Medicines Guideline for Conditional Approval of Medicines January 29, 2021 %e1%8b%a8%e1%88%98%e1%8b%b5%e1%8a%83%e1%8a%92%e1%89%b5-%e1%8c%8b%e1%8b%ad%e1%8b%b5%e1%88%8b%e1%8b%ad%e1%8a%95 Pharmaceutical Products Traceability Directive Pharmaceutical Products Traceability Directive January 13, 2021 traceability-amh Pharmacovigilance Directive Amharic 2020 Pharmacovigilance Directive Amharic 2020 December 30, 2020 %e1%8b%a8%e1%88%98%e1%8b%b5%e1%8a%83%e1%8a%92%e1%89%b5-%e1%88%98%e1%88%98%e1%88%aa%e1%8b%ab%e1%8b%8e%e1%89%bd %e1%8b%a8%e1%8d%8b%e1%88%ad%e1%88%9b%e1%8a%ae%e1%89%aa%e1%8c%82%e1%88%8b%e1%8a%95%e1%88%b5-%e1%88%98%e1%8d%85%e1%88%84%e1%89%b5 %e1%88%98%e1%8c%bd%e1%88%94%e1%89%b6%e1%89%bd%e1%8a%93-%e1%8a%a5%e1%8a%93-%e1%89%a0%e1%88%ab%e1%88%a8-%e1%8c%bd%e1%88%91%e1%8d%8e%e1%89%bd Guideline for Conditional approval of medicines 2020 Guideline for Conditional approval of medicines 2020 December 16, 2020 %e1%8b%a8%e1%88%98%e1%8b%b5%e1%8a%83%e1%8a%92%e1%89%b5-%e1%8c%8b%e1%8b%ad%e1%8b%b5%e1%88%8b%e1%8b%ad%e1%8a%95 Supplementary guideline for Clinical trial Authorization 2020 Supplementary guideline for Clinical trial Authorization 2020 November 9, 2020 %e1%8b%a8%e1%88%98%e1%8b%b5%e1%8a%83%e1%8a%92%e1%89%b5-%e1%8c%8b%e1%8b%ad%e1%8b%b5%e1%88%8b%e1%8b%ad%e1%8a%95 Guideline for Registration of oral care skin care products with therapeutic claim Guideline for Registration of oral care skin care products with therapeutic claim October 9, 2020 %e1%8b%a8%e1%88%98%e1%8b%b5%e1%8a%83%e1%8a%92%e1%89%b5-%e1%8c%8b%e1%8b%ad%e1%8b%b5%e1%88%8b%e1%8b%ad%e1%8a%95 Good Review Practices (GRevPs) Guideline Good Review Practices (GRevPs) Guideline October 1, 2020 %e1%8b%a8%e1%88%98%e1%8b%b5%e1%8a%83%e1%8a%92%e1%89%b5-%e1%8c%8b%e1%8b%ad%e1%8b%b5%e1%88%8b%e1%8b%ad%e1%8a%95 Guideline for WHO Pre-qualified Medicines through Collaborative Registration Procedure Guideline for WHO Pre-qualified Medicines through Collaborative Registration Procedure October 1, 2020 %e1%8b%a8%e1%88%98%e1%8b%b5%e1%8a%83%e1%8a%92%e1%89%b5-%e1%8c%8b%e1%8b%ad%e1%8b%b5%e1%88%8b%e1%8b%ad%e1%8a%95 Guideline for Registration of Low-risk Medicines Guideline for Registration of Low-risk Medicines October 1, 2020 %e1%8b%a8%e1%88%98%e1%8b%b5%e1%8a%83%e1%8a%92%e1%89%b5-%e1%8c%8b%e1%8b%ad%e1%8b%b5%e1%88%8b%e1%8b%ad%e1%8a%95 Risk-based Guideline for Post-Marketing Quality Surveillance PMS Guideline 2020 September 25, 2020 %e1%8b%a8%e1%88%98%e1%8b%b5%e1%8a%83%e1%8a%92%e1%89%b5-%e1%8c%8b%e1%8b%ad%e1%8b%b5%e1%88%8b%e1%8b%ad%e1%8a%95 RDU Directive RDU Directive September 23, 2020 %e1%8b%a8%e1%88%98%e1%8b%b5%e1%8a%83%e1%8a%92%e1%89%b5-%e1%88%98%e1%88%98%e1%88%aa%e1%8b%ab%e1%8b%8e%e1%89%bd Food Consignment Technical guideline Food Consignment Technical guideline September 22, 2020 food-guidelines-amh Good Review Practices (GRevPs) Guideline August 25, 2020 %e1%8b%a8%e1%88%98%e1%8b%b5%e1%8a%83%e1%8a%92%e1%89%b5-%e1%88%98%e1%88%98%e1%88%aa%e1%8b%ab%e1%8b%8e%e1%89%bd Guidelines for WHO Pre-qualified Medicines through Collaborative Registration Procedure August 25, 2020 %e1%8b%a8%e1%88%98%e1%8b%b5%e1%8a%83%e1%8a%92%e1%89%b5-%e1%88%98%e1%88%98%e1%88%aa%e1%8b%ab%e1%8b%8e%e1%89%bd Guideline for Registration of Low-Risk Medicines August 25, 2020 %e1%8b%a8%e1%88%98%e1%8b%b5%e1%8a%83%e1%8a%92%e1%89%b5-%e1%8c%8b%e1%8b%ad%e1%8b%b5%e1%88%8b%e1%8b%ad%e1%8a%95 PV Newsletter V7 ISSUE 2 Feb 2020 Pharmacovigilance newsletter No 2 2012 July 8, 2020 %e1%8b%a8%e1%8d%8b%e1%88%ad%e1%88%9b%e1%8a%ae%e1%89%aa%e1%8c%82%e1%88%8b%e1%8a%95%e1%88%b5-%e1%88%98%e1%8d%85%e1%88%84%e1%89%b5 %e1%88%98%e1%8c%bd%e1%88%94%e1%89%b6%e1%89%bd%e1%8a%93-%e1%8a%a5%e1%8a%93-%e1%89%a0%e1%88%ab%e1%88%a8-%e1%8c%bd%e1%88%91%e1%8d%8e%e1%89%bd PV Newsletter V7 Issue 1 Oct 2019 Pharmacovigilance newsletter No 2 2012 July 8, 2020 %e1%8b%a8%e1%8d%8b%e1%88%ad%e1%88%9b%e1%8a%ae%e1%89%aa%e1%8c%82%e1%88%8b%e1%8a%95%e1%88%b5-%e1%88%98%e1%8d%85%e1%88%84%e1%89%b5 %e1%88%98%e1%8c%bd%e1%88%94%e1%89%b6%e1%89%bd%e1%8a%93-%e1%8a%a5%e1%8a%93-%e1%89%a0%e1%88%ab%e1%88%a8-%e1%8c%bd%e1%88%91%e1%8d%8e%e1%89%bd Annexes to cosmetic product manufacturing Directive No. 49/2020 Annexes to cosmetic product manufacturing Directive No. 49 2020 June 17, 2020 %e1%8b%a8%e1%8a%ae%e1%88%b5%e1%88%9e%e1%89%b2%e1%8a%ad%e1%88%b5-%e1%88%98%e1%88%98%e1%88%aa%e1%8b%ab%e1%8b%8e%e1%89%bd Cosmetic manufacturer Directive 2020 Cosmetic manufacturer Directive 2020 June 17, 2020 %e1%8b%a8%e1%8a%ae%e1%88%b5%e1%88%9e%e1%89%b2%e1%8a%ad%e1%88%b5-%e1%88%98%e1%88%98%e1%88%aa%e1%8b%ab%e1%8b%8e%e1%89%bd Food and Medicine Administration Proclamation No.1112/2019 Food and Medicine Administration Proclamation 1112 June 10, 2020 %e1%8a%a0%e1%8b%8b%e1%8c%85 %e1%8d%96%e1%88%8a%e1%88%b2%e1%8b%8e%e1%89%bd%e1%8d%a3-%e1%88%95%e1%8c%8e%e1%89%bd-%e1%8a%a5%e1%8a%93-%e1%8b%b0%e1%8a%95%e1%89%a6%e1%89%bd Internal quality Food import export Internal quality Food import export June 5, 2020 %e1%8b%a8%e1%88%9d%e1%8c%8d%e1%89%a5-%e1%88%98%e1%88%98%e1%88%aa%e1%8b%ab%e1%8b%8e%e1%89%bd Traditional Medicine Guidance Traditional Medicine Guidance May 26, 2020 %e1%8b%a8%e1%88%98%e1%8b%b5%e1%8a%83%e1%8a%92%e1%89%b5-%e1%8c%8b%e1%8b%ad%e1%8b%b5%e1%88%8b%e1%8b%ad%e1%8a%95 Cloth Mask Directive Cloth Mask Directive May 14, 2020 የኮሮና ቫይረስ ግብአት አምራች፣ አስመጪና አከፋፋይ ድርጅት የብቃት ማረጋገጫ የምስክር ወረቀት አሰጣጥ ጊዜያዊ መመርያ Temporary Licensing Procedures April 13, 2020 ለኮሮና ቫይረስ ወረርሽኝ የሚውሉ ግብዓቶችን ወደ ሀገር ውስጥ ስለማስገባት የወጣ ጊዜያዊ የአሰራር መመርያ Import Covid Directive April 13, 2020 Temporary COVID-19 Medical Product Approval and Import Permit Authorization Directive Temporary COVID-19 Medical Product Approval and Import Permit Authorization Directive April 10, 2020 Annexes to Cosmetics Import, Export and Wholesale Control Directive No. 48/2020 AnnexeAnnexes to Cosmetics Import Export and Wholesale Control Directive No 482020s to Cosmetics Import Export and Wholesale Control Directive No 482020 April 1, 2020 %e1%8b%a8%e1%8a%ae%e1%88%b5%e1%88%9e%e1%89%b2%e1%8a%ad%e1%88%b5-%e1%88%98%e1%88%98%e1%88%aa%e1%8b%ab%e1%8b%8e%e1%89%bd Cosmetics Import, Export and Wholesale Control Directive No 331-2020 331 Cosmetics, Import, Export and Whole sale Control Directive No 331-2020 April 1, 2020 %e1%8b%a8%e1%8a%ae%e1%88%b5%e1%88%9e%e1%89%b2%e1%8a%ad%e1%88%b5-%e1%88%98%e1%88%98%e1%88%aa%e1%8b%ab%e1%8b%8e%e1%89%bd የኮሮና ቫይረስ ወረርሺኝን ለመከላከል ኅብረተሰቡ የሚጠቀምባቸው የመከላከያ ምርቶች አምራች፣ አስመጪ እና አከፋፋይ የብቃት ማረጋገጫ የምስክር አሰጣጥ ጊዜያዊ የአሠራር መመሪያ፡፡ 2012 የኮሮና ቫይረስ ወረርሺኝን ለመከላከል ኅብረተሰቡ የሚጠቀምባቸው የመከላከያ ምርቶች አምራች፣ አስመጪ እና አከፋፋይ የብቃት ማረጋገጫ የምስክር አሰጣጥ ጊዜያዊ የአሠራር መመሪያ፡፡ 2012 March 25, 2020 %e1%8b%a8%e1%88%98%e1%8b%b5%e1%8a%83%e1%8a%92%e1%89%b5-%e1%88%98%e1%88%98%e1%88%aa%e1%8b%ab%e1%8b%8e%e1%89%bd Rational Medicine Use Directive 2019 Rational Medicine Use Directive 2019 July 5, 2019 %e1%8b%a8%e1%88%98%e1%8b%b5%e1%8a%83%e1%8a%92%e1%89%b5-%e1%88%98%e1%88%98%e1%88%aa%e1%8b%ab%e1%8b%8e%e1%89%bd Food registration directive 2019 Food registration directive 2019 July 5, 2019 %e1%8b%a8%e1%88%9d%e1%8c%8d%e1%89%a5-%e1%88%98%e1%88%98%e1%88%aa%e1%8b%ab%e1%8b%8e%e1%89%bd Alcohol Advertisement and Labeling Control Directive No 41/2019 Alcohol-Advertisement ald Labeling Control Directive No 41 2019 June 18, 2019 Tobacco Control Directive English version March 2015 WHEREAS, tobacco products have serious health, social, economic and environmental consequences; WHEREAS, tobacco consumption has been scientifically confirmed to cause serious ailments including cancer, respiratory disease, cardiac and blood vessel diseases; disability as well as … April 19, 2019 National Drug Policy …….Based on economic development and the living standard of its people Ethiopia is considered to be one of the least developed countries. Although the fundamental cause for this is the backward socio-economic system which prevailed … April 8, 2019 %e1%8d%96%e1%88%8a%e1%88%b2%e1%8b%8e%e1%89%bd %e1%8d%96%e1%88%8a%e1%88%b2%e1%8b%8e%e1%89%bd%e1%8d%a3-%e1%88%95%e1%8c%8e%e1%89%bd-%e1%8a%a5%e1%8a%93-%e1%8b%b0%e1%8a%95%e1%89%a6%e1%89%bd Strategic plan For Traceability Implementation Ethiopia has one of the fastest growing economies in the world. However, production capacity, technological developments, creation of employment opportunities and investments in the healthcare sector are behind on other sectors (HSTP, 2015), while at … March 7, 2019 traceability-amh
EFDA
Ethiopian Food and Drug Administration
ሁሉም ሕትመቶች
You are here:
- Home
- ሁሉም ሕትመቶች